See more : Toho Chemical Industry Company, Limited (4409.T) Income Statement Analysis – Financial Results
Complete financial analysis of LIMES Schlosskliniken AG (LIK.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of LIMES Schlosskliniken AG, a leading company in the Medical – Care Facilities industry within the Healthcare sector.
- Forza Innovations Inc. (FORZ) Income Statement Analysis – Financial Results
- NexTech AR Solutions Corp. (NTAR.CN) Income Statement Analysis – Financial Results
- Macquarie Group Limited (MQG.AX) Income Statement Analysis – Financial Results
- SpareBank 1 Nord-Norge (SPXXF) Income Statement Analysis – Financial Results
- EBM Technologies Incorporated (8409.TWO) Income Statement Analysis – Financial Results
LIMES Schlosskliniken AG (LIK.DE)
About LIMES Schlosskliniken AG
LIMES Schlosskliniken AG operates private hospitals for psychiatry, psychotherapy, and psychosomatics services. It focuses on the treatment of stress-related illnesses, as well as mental and emotional disorders, such as depression, acute burnout, affective disorders, and trauma. The company is headquartered in Cologne, Germany. LIMES Schlosskliniken AG is a subsidiary of GMF Capital Gmbh.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|
| Revenue | 37.17M | 28.81M | 23.43M | 11.02M | 8.18M | 7.56M | 6.54M |
| Cost of Revenue | 20.94M | 17.99M | 15.06M | 8.21M | 6.10M | 5.29M | 4.94M |
| Gross Profit | 16.23M | 10.82M | 8.37M | 2.80M | 2.08M | 2.27M | 1.59M |
| Gross Profit Ratio | 43.66% | 37.55% | 35.73% | 25.45% | 25.39% | 29.98% | 24.39% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 4.09M | 4.13M | 4.23M | 2.66M | 2.20M | 51.47K | 31.32K |
| Selling & Marketing | 2.73M | 1.93M | 1.42M | 735.57K | 557.37K | 550.58K | 433.88K |
| SG&A | 6.82M | 6.06M | 5.64M | 3.40M | 2.76M | 1.09M | 1.71M |
| Other Expenses | 4.39M | 1.24M | 1.80M | 165.18K | 139.04K | 131.76K | 159.04K |
| Operating Expenses | 11.21M | 4.82M | 3.84M | 3.23M | 2.62M | -3.19M | -2.31M |
| Cost & Expenses | 32.15M | 22.81M | 18.91M | 11.44M | 8.72M | 2.10M | 2.63M |
| Interest Income | 0.00 | 391.61K | 224.23K | 264.16K | 284.30K | 533.53K | 537.65K |
| Interest Expense | 0.00 | 391.61K | 224.23K | 264.16K | 284.30K | 533.53K | 537.65K |
| Depreciation & Amortization | 2.65M | 2.65M | 1.49M | 1.26M | 802.91K | 798.05K | 229.89K |
| EBITDA | 7.67M | 8.65M | 6.02M | 837.74K | 263.28K | -129.24K | -486.24K |
| EBITDA Ratio | 20.64% | 30.04% | 25.67% | 7.59% | 3.20% | -1.71% | -7.44% |
| Operating Income | 5.03M | 6.00M | 4.53M | -428.37K | -540.74K | -927.29K | -716.13K |
| Operating Income Ratio | 13.52% | 20.82% | 19.33% | -3.89% | -6.61% | -12.27% | -10.96% |
| Total Other Income/Expenses | -440.56K | -391.61K | -224.23K | -265.69K | -285.40K | -534.21K | -536.74K |
| Income Before Tax | 4.59M | 5.61M | 4.31M | -692.54K | -825.04K | -1.46M | -1.25M |
| Income Before Tax Ratio | 12.34% | 19.46% | 18.37% | -6.29% | -10.08% | -19.32% | -19.17% |
| Income Tax Expense | 676.46K | 742.69K | 197.01K | 1.88K | 1.10K | 1.60M | 180.00 |
| Net Income | 3.40M | 4.20M | 3.94M | -694.42K | -825.04K | -1.46M | -1.25M |
| Net Income Ratio | 9.14% | 14.59% | 16.83% | -6.30% | -10.08% | -19.32% | -19.17% |
| EPS | 11.58 | 14.34 | 13.45 | -2.37 | -2.81 | -5.26 | -4.51 |
| EPS Diluted | 11.58 | 14.34 | 13.45 | -2.37 | -2.81 | -5.26 | -4.51 |
| Weighted Avg Shares Out | 293.19K | 293.19K | 293.19K | 293.19K | 293.19K | 277.64K | 277.64K |
| Weighted Avg Shares Out (Dil) | 293.19K | 293.19K | 293.19K | 293.19K | 293.19K | 277.64K | 277.64K |
Source: https://incomestatements.info
Category: Stock Reports